Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Arizona
University of Wisconsin, Madison
Mayo Clinic
St. Jude Children's Research Hospital
Baylor College of Medicine
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Stanford University
Stanford University
University Hospital, Basel, Switzerland
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center
Scripps Health
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Novartis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Celgene
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
University of Rochester
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cellerant Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of South Florida
University of South Florida
National Cancer Institute (NCI)